RecruitingPhase 2NCT07314060

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

Studying DITRA

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Intervention: TQH2929 Injections(drug)
Enrollment: 36 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2026 – 2027

Study locations (30)

Peking University First Hospita, Beijing, Beijing Municipality, China
Peking University Third Hospital, Beijing, Beijing Municipality, China
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Southern Medical University Dermatology Hospital, Guangzhou, Guangdong, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
The Second Hospital Of Hebei Medical University, Shijiazhuang, Hebei, China
The Second Affiliated Hospital of Henan University of science and technology, Luoyang, Henan, China
Zhengzhou Central Hospital, Zhengzhou, Henan, China
Henan Provincial People's Hospital, Zhengzhou, Henan, China
The fifth Affiliated hospital of zhengzhou university, Zhengzhou, Henan, China
Shiyan Renmin Hospital, Shiyan, Hubei, China
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07314060 on ClinicalTrials.gov

Other trials for DITRA

Additional recruiting or active studies for the same condition.

See all trials for DITRA →

← Back to all trials